MENU
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
UroGen Pharma (URGN) Earnings Date & Reports
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
URGN is expected to report earnings to fall 89.62% to -4 cents per share on November 05
Q3'26
Est.
$-0.05
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.06
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.22
The last earnings report on May 06 showed earnings per share of -46 cents, beating the estimate of -50 cents. With 382.79K shares outstanding, the current market capitalization sits at 2.07B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies for urological pathologies
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
291
Web
https://www.urogen.com